AGLE 102 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
36表皮水疱症1

36. 表皮水疱症


臨床試験数 : 163 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04173650
(ClinicalTrials.gov)
October 202318/11/2019MSC EVs in Dystrophic Epidermolysis BullosaA Safety Study of the Administration of Mesenchymal Stem Cell Extracellular Vesicles in the Treatment of Dystrophic Epidermolysis Bullosa WoundsDystrophic Epidermolysis BullosaDrug: AGLE 102Aegle TherapeuticsNULLNot yet recruiting6 YearsN/AAll10Phase 1/Phase 2NULL